Sanofi: updates and filings

SNYNASDAQHealthcare · Pharmaceutical Preparations

Price

$46.52

November 20, 2026Market cap $113B

What Ploutos Investor adds for Sanofi

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 11 fiscal years, from 2015
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 17, 2026 latest annual
  • Nov 5, 2026Its own holdings as an investment manager (13F)
    Form13F-HR
  • Oct 30, 2026Current report (foreign company)
    Form6-K
  • Oct 26, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Oct 26, 2026Current report (foreign company)
    Form6-K
  • Oct 1, 2026Current report (foreign company)
    Form6-K
  • Sep 17, 2026Current report (foreign company)
    Form6-K
  • Aug 25, 2026Filing
    FormN-PX
  • Aug 6, 2026Current report (foreign company)
    Form6-K
  • Jul 30, 2026Current report (foreign company)
    Form6-K
  • Jul 30, 2026Current report (foreign company)
    Form6-K
  • Jul 28, 2026Its own holdings as an investment manager (13F)
    Form13F-HR
  • Jul 27, 2026Current report (foreign company)
    Form6-K
  • Jul 22, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jul 17, 2026Current report (foreign company)
    Form6-K
  • Jul 7, 2026Current report (foreign company)
    Form6-K
  • Jun 30, 2026Employee stock plan reportfor the period to Dec 31, 2025
    Form11-K
  • Jun 30, 2026Employee stock plan reportfor the period to Dec 31, 2025
    Form11-K
  • Jun 30, 2026Filing
    FormNT 11-K
  • Jun 30, 2026Filing
    FormNT 11-K
  • Jun 24, 2026Current report (foreign company)
    Form6-K
  • Jun 22, 2026Current report (foreign company)
    Form6-K
  • Jun 12, 2026Current report (foreign company)
    Form6-K
  • Jun 8, 2026Current report (foreign company)
    Form6-K
  • May 28, 2026Conflict minerals report
    FormSD
  • May 27, 2026Current report (foreign company)
    Form6-K

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Jan 8, 2001: every report, 8-K, meeting and letter. Of its other filings (1,419 in all), the newest.

The full analysis

What do Sanofi's filings show?

The filings are where every one of Sanofi's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.